LONDON BROKER RATINGS: Berenberg cuts Whitbread; Citi ups Severn Trent
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More
| Price | 172.20p on 06-02-2026 at 19:35:05 |
|---|---|
| Change | 5.60p 3.36% |
| Buy | 172.20p |
| Sell | 172.00p |
| Last Trade: | Buy 224,851.00 at 172.20p |
| Day's Volume: | 1,550,697 |
| Last Close: | 172.20p |
| Open: | 163.00p |
| ISIN: | GB00B012BV22 |
| Day's Range | 163.00p - 172.60p |
| 52wk Range: | 155.00p - 295.00p |
| Market Capitalisation: | £435.41m |
| VWAP: | 168.21307p |
| Shares in Issue: | 252.85m |
Marshalls (MSLH) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 224,851 | 172.20p | Suspected BUY Trade |
16:35:02 - 06-Feb-26 |
| Sell* | 15 | 172.00p | SI Trade |
16:26:41 - 06-Feb-26 |
| Sell* | 556 | 172.00p | Automatic Execution |
16:26:33 - 06-Feb-26 |
| Buy* | 746 | 172.20p | Automatic Execution |
16:26:33 - 06-Feb-26 |
| Buy* | 700 | 172.00p | Automatic Execution |
16:26:33 - 06-Feb-26 |
| Buy* | 637 | 172.00p | Automatic Execution |
16:26:33 - 06-Feb-26 |
| Buy* | 603 | 172.00p | Automatic Execution |
16:26:33 - 06-Feb-26 |
| Buy* | 462 | 172.00p | Automatic Execution |
16:26:33 - 06-Feb-26 |
| Buy* | 538 | 172.00p | Automatic Execution |
16:26:33 - 06-Feb-26 |
| Buy* | 1,273 | 172.00p | Automatic Execution |
16:26:33 - 06-Feb-26 |
Marshalls (MSLH) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 19th Jan 2026 7:01 am | RNS | Trading Statement |
| 19th Jan 2026 7:00 am | RNS | Directorate change |
| 9th Jan 2026 12:40 pm | RNS | Director/PDMR Shareholding |
| 9th Jan 2026 12:38 pm | RNS | Director/PDMR Shareholding |
| 6th Jan 2026 9:36 am | RNS | Notice of Trading Update |
| 9th Dec 2025 3:21 pm | RNS | Director/PDMR Shareholding |
| 27th Nov 2025 7:00 am | RNS | Board changes |
| 12th Nov 2025 7:00 am | RNS | Trading Update |
| 10th Nov 2025 10:30 am | RNS | Director/PDMR Shareholding |
| 10th Nov 2025 10:29 am | RNS | Director/PDMR Shareholding |